e-therapeutics PLC's (LON:ETX) Chairman Ali Mortazavi talks to Proactive London about taking over CEO duties.
Mortazavi, formerly the boss of Silence Therapeutics, took over the helm at e-therapeutics after doing extensive due diligence on the company’s drug discovery platform.
The company has a computer-based platform to assist in drug discovery and Mortazavi believes it has established a key position among the small vanguard of companies across the globe applying computational biology to drug discovery.